HALO - Margin dodolan operasi Halozyme

Logo korporat perusahaan Halozyme Corp (HALO)

The global influence of Halozyme Therapeutics (HALO) is based on Big Pharma's dependence on its subcutaneous administration patents. The current operating margin confirms the effectiveness of technology licensing and partner royalties, as well as R&D successes in oncology. The value of 56.70 captures the current state of the parameter, demonstrating the dynamics of operating profit relative to revenue.

halozyme.com (HALO): Margin dodolan operasi saka 04.07.2022 nganti 20.11.2026

Halozyme - rincian analitis lan metrik utama (HALO)

- statistik kapitalisasi pasar:
Pambiji fundamental:Halozyme Inc., HALO
Produk merek halozyme.com

It is critical for investors to filter the risks associated with Halozyme Therapeutics (HALO) by assessing the business's ability to generate operating profit before taxes and interest amidst geopolitical barriers in reagent logistics. An analysis of the operating profit margin reveals the company's real efficiency, demonstrating the fundamental strength and resilience of the operating model to external shocks, which confirms the long-term reliability of the asset.

Analisis pesaing Halozyme Therapeutics

Rentabilitas operasi BeiGene Ltd|Rentabilitas operasi RVMD|Margin dodolan operasi AAPG (Ascentage)|Margin dodolan operasi cgoncology.com CGON|UroGen Pharma - Margin dodolan operasi|Tingkat bathi operasi BCAX|PSNL - Rentabilitas operasi|Rentabilitas kegiatan operasi Erasca Oncology ERAS|delcath.com (DCTH) - Rentabilitas operasi|Y-mAbs Therapeutics - Tingkat bathi operasi|AURA (Aura Biosciences Inc) - Margin operasi|Rentabilitas dodolan operasi candeltx.com CADL|Margin operasi ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Tingkat bathi operasi|Rentabilitas operasi Actuate Therapeutics, Inc. ACTU|citiusonc.com - Rentabilitas operasi|TuHURA Biosciences Inc. - Margin operasi|TARA - Margin operasi|FATE (Fate Therapeutics) - Margin dodolan operasi|Margin dodolan operasi Aadi Bioscience, Inc.|Margin dodolan operasi TCRX|Rentabilitas operasi CSBR|Margin operasi XBIT|Rentabilitas kegiatan operasi CEL-SCI Corp.|Rentabilitas operasi ostherapies.com OSTX|RADX: Rentabilitas dodolan miturut bathi operasi|ARTV: Margin dodolan operasi|ANL (Adlai Nortye) - Rentabilitas dodolan miturut bathi operasi|Veru (VERU) - Rentabilitas operasi|Margin dodolan operasi Tempest Therapeutics Inc|Rentabilitas operasi Xilio Therapeutics|Rentabilitas dodolan miturut bathi operasi RENB (Renovaro Inc.)|Rentabilitas operasi Mural Oncology PLC (MURA)|Margin operasi Kairos Pharma (KAPA)|Rentabilitas operasi onkuretherapeutics.com OKUR|GDTC: Rentabilitas dodolan miturut bathi operasi|CRIS: Margin dodolan operasi|apollomicsinc.com (APLM) - Margin dodolan operasi|THAR: Margin operasi|Margin dodolan operasi Advanced Biomed Inc.|Margin dodolan operasi GNPX|Rentabilitas dodolan miturut bathi operasi CLDI (Calidi Biotherapeutics)|Margin operasi SBFM|Xenetic Biosciences, Inc. - Rentabilitas dodolan miturut bathi operasi|Rentabilitas operasi Salarius Pharmaceuticals SLRX|Margin operasi purple-biotech.com PPBT|AONC - Rentabilitas operasi|BGNE: Rentabilitas operasi|CKPT: Margin operasi|Elevation Oncology - Tingkat bathi operasi|ICAD (iCAD) - Margin operasi|IKNA: Tingkat bathi operasi|Rentabilitas operasi Notable Labs (NTBL)|VIRX (Viracta Therapeutics, Inc.) - Tingkat bathi operasi|Rentabilitas operasi MorphoSys Corporation MOR|NAYA: Rentabilitas dodolan miturut bathi operasi|Ascentage Pharma Group International - Margin operasi